{"id":"https://openalex.org/W1968236091","doi":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","title":"Effect of sitagliptin, a dipeptidyl peptidase\u20104 inhibitor, on beta\u2010cell function in patients with type 2 diabetes: a model\u2010based approach","display_name":"Effect of sitagliptin, a dipeptidyl peptidase\u20104 inhibitor, on beta\u2010cell function in patients with type 2 diabetes: a model\u2010based approach","alternate_titles":[],"publication_year":2008,"publication_date":"2008-10-29","ids":{"openalex":"https://openalex.org/W1968236091","doi":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","mag":"1968236091","pmid":"https://pubmed.ncbi.nlm.nih.gov/18476982"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2008.00887.x","doi":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968236091"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100331716","display_name":"Lei Xu","orcid":"https://orcid.org/0000-0002-9241-7019","observed_orcids":["https://orcid.org/0000-0002-9241-7019"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Xu","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ 07065, USA","Merck Research Laboratories, Rahway, NJ (USA)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ 07065, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ (USA)","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068823308","display_name":"Chiara Dalla Man","orcid":"https://orcid.org/0000-0002-4908-0596","observed_orcids":["https://orcid.org/0000-0002-4908-0596"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Dalla Man","raw_affiliation_strings":["Department of Information Engineering, University of Padova, Padova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Information Engineering, University of Padova, Padova, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025169113","display_name":"Bernard H. Charbonnel","orcid":"https://orcid.org/0000-0002-2117-9279","observed_orcids":["https://orcid.org/0000-0002-2117-9279"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Charbonnel","raw_affiliation_strings":["Department of Endocrinology Centre Hospitalier Universitaire de Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology Centre Hospitalier Universitaire de Nantes, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076586778","display_name":"G. Meninger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Meninger","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024193480","display_name":"Michael J. Davies","orcid":"https://orcid.org/0000-0003-1526-0801","observed_orcids":["https://orcid.org/0000-0003-1526-0801"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. J. Davies","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022896675","display_name":"Debora Williams\u2010Herman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"D. Williams\u2010Herman","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026228486","display_name":"Claudio Cobelli","orcid":"https://orcid.org/0000-0002-0169-6682","observed_orcids":["https://orcid.org/0000-0002-0169-6682"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Cobelli","raw_affiliation_strings":["Department of Information Engineering, University of Padova, Padova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Information Engineering, University of Padova, Padova, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109140065","display_name":"Peter P. Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. P. Stein","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022896675"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":6.4768,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.97362908,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"10","issue":"12","first_page":"1212","last_page":"1220"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8569999933242798},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.8970000147819519},{"id":"https://openalex.org/keywords/insulin-secretion-rate","display_name":"insulin secretion rate","score":0.8349999785423279},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.6100000143051147},{"id":"https://openalex.org/keywords/disposition-index","display_name":"disposition index","score":0.824999988079071},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.6740000247955322},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.765999972820282},{"id":"https://openalex.org/keywords/pharmacodynamic-modeling","display_name":"pharmacodynamic modeling","score":0.4749999940395355},{"id":"https://openalex.org/keywords/meal-tolerance-test","display_name":"meal tolerance test","score":0.5490000247955322},{"id":"https://openalex.org/keywords/basal-insulin-secretion","display_name":"basal insulin secretion","score":0.5759999752044678}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.8869641423225403},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.734394907951355},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7148392200469971},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6306626796722412},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5997427105903625},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5747968554496765},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4637053608894348},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4366748332977295},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.4150884747505188},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41316333413124084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37665313482284546},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.36075225472450256},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21523717045783997},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1463-1326.2008.00887.x","doi":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2008.00887.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:18476982","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18476982","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:www.research.unipd.it:11577/2437535","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11577/2437535","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1585447752","https://openalex.org/W1945989183","https://openalex.org/W1973489602","https://openalex.org/W1975588287","https://openalex.org/W1993930772","https://openalex.org/W1994743271","https://openalex.org/W1996407482","https://openalex.org/W2010615417","https://openalex.org/W2018192866","https://openalex.org/W2030347165","https://openalex.org/W2037211078","https://openalex.org/W2051462052","https://openalex.org/W2083473802","https://openalex.org/W2084644316","https://openalex.org/W2085862152","https://openalex.org/W2106558322","https://openalex.org/W2123629330","https://openalex.org/W2133795831","https://openalex.org/W2145335273","https://openalex.org/W2154615287","https://openalex.org/W2159205789","https://openalex.org/W2169513674","https://openalex.org/W2171512247"],"related_works":["https://openalex.org/W2066816981","https://openalex.org/W1978432888","https://openalex.org/W4284881278","https://openalex.org/W1996407482","https://openalex.org/W1981985904","https://openalex.org/W2774119304","https://openalex.org/W2082289458","https://openalex.org/W2020543244","https://openalex.org/W2116492775","https://openalex.org/W4205965838"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,177,325],"purpose":[2],"of":[3,12,61,71,103,166,194,219,229,275],"this":[4,29,348],"exploratory":[5],"analysis":[6,30],"was":[7,201,245,287,311,317],"to":[8,46,64,100,163,259,279,298,309,344,356],"assess":[9,213],"the":[10,101,124,136,164,185,217,227,306,328],"effect":[11],"sitagliptin,":[13],"a":[14,23,72,104,155,174,192,204,255,288],"dipeptidyl":[15],"peptidase-4":[16],"inhibitor,":[17],"on":[18],"pancreatic":[19],"beta-cell":[20,119,353],"function":[21,120,193,354],"using":[22,123],"model-based":[24,349],"analysis.":[25],"METHODS:":[26],"Data":[27],"for":[28,110,118,327],"were":[31,85,108,121,224,334],"from":[32],"three":[33],"large,":[34],"placebo-controlled":[35],"clinical":[36],"studies":[37],"that":[38],"examined":[39],"sitagliptin":[40,244,296,302,322,341,351],"100":[41],"mg":[42],"q.d.":[43],"as":[44,50,69,191,226,242,282],"add-on":[45],"metformin":[47,239,280],"therapy":[48,240],"or":[49,54,241,281],"monotherapy":[51],"over":[52,184],"18":[53],"24":[55],"weeks.":[56],"In":[57,347],"these":[58],"studies,":[59],"subsets":[60],"patients":[62,365],"consented":[63],"undergo":[65],"extensive":[66],"blood":[67],"sampling":[68],"part":[70],"nine-point":[73],"meal":[74,105,256],"tolerance":[75],"test":[76],"performed":[77],"at":[78,87,142,149],"baseline":[79],"and":[80,96,106,113,134,157,323,331,361],"study":[81],"end-point.":[82],"Blood":[83],"samples":[84],"collected":[86],"-10,":[88],"0,":[89],"10,":[90],"20,":[91],"30,":[92],"60,":[93],"90,":[94],"120":[95],"180":[97],"min":[98],"relative":[99,258,297,308,343,355],"start":[102],"subsequently":[107],"assayed":[109],"plasma":[111],"glucose":[112,144,152,171,187],"serum":[114],"C-peptide":[115,125],"concentrations.":[116],"Parameters":[117],"calculated":[122,190,225],"minimal":[126],"model,":[127],"which":[128,212],"estimates":[129],"insulin":[130,214,222],"secretion":[131,215],"rate":[132,165],"(ISR)":[133],"partitions":[135],"ISR":[137,141,148,160,183],"into":[138],"basal":[139,143,151,170],"(Phi(b);":[140],"concentrations),":[145],"static":[146],"(Phi(s);":[147],"above":[150,169],"concentrations":[153,172],"following":[154,173,254],"meal)":[156,175],"dynamic":[158,330],"(Phi(d);":[159],"in":[161,168,216,221,235,250,270,358,364],"response":[162],"increase":[167],"components.":[176],"total":[178,332],"responsivity":[179],"index":[180,207],"(Phi(total);":[181],"average":[182,186],"concentration)":[188],"is":[189],"Phi(s),":[195],"Phi(d":[196],")and":[197,272],"Phi(b.":[198],")Insulin":[199],"sensitivity":[200],"assessed":[202],"with":[203,237,247,295,301,314,340,366],"validated":[205],"composite":[206],"(ISI).":[208],"Disposition":[209],"indices":[210],"(DI),":[211],"context":[218],"changes":[220],"sensitivity,":[223],"product":[228],"Phiand":[230],"ISI.":[231],"RESULTS:":[232],"When":[233],"administered":[234],"combination":[236],"ongoing":[238],"monotherapy,":[243],"associated":[246],"substantial":[248],"reductions":[249],"postprandial":[251,362],"glycaemic":[252],"excursion":[253],"challenge":[257],"placebo.":[260,299,324,345],"Sitagliptin":[261],"produced":[262],"significant":[263,313],"(p":[264,336],"<":[265,337],"0.05":[266],"vs.":[267],"placebo)":[268],"improvements":[269],"Phi(s":[271],"Phi(total),":[273],"regardless":[274],"treatment":[276,342],"regimen":[277],"(add-on":[278],"monotherapy).":[283],"For":[284],"Phi(d),":[285],"there":[286],"numerical,":[289],"but":[290,305],"not":[291,318],"statistically":[292],"significant,":[293],"improvement":[294],"Treatment":[300],"increased":[303,339],"Phi(b),":[304],"difference":[307],"placebo":[310,357],"only":[312],"monotherapy.":[315],"ISI":[316],"significantly":[319,335],"different":[320],"between":[321],"DIs":[326],"static,":[329],"measures":[333],"0.05)":[338],"CONCLUSIONS:":[346],"analysis,":[350],"improved":[352],"both":[359],"fasting":[360],"states":[363],"type":[367],"2":[368],"diabetes.":[369]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968236091","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
